1-10 of 10
Mu Hao, PhD.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Monitoring the Cytogenetic Architecture of Minimal Residual Plasma Cells Indicates Therapy-Induced Clonal Selection in Multiple Myeloma

Yuting Yan, Yan Xu, Xuehan Mao, MD, Jiahui Liu, Huishou Fan, Qi Wang, Chenxing Du, Li Zengjun, Shuhua Yi, MD, Rui Lv, Shuhui Deng, MD, Weiwei Sui, Mu Hao, PhD, Yu-Tzu Tai, PhD, Nikhil C. Munshi, MD, Gang An, MD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4405.
https://doi.org/10.1182/blood-2019-124096
Published: 2019
Journal Articles

Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Lanting LIU, Fengyan Jin, Jiaojiao Guo, An Gang, MD, Xiaoqi Qin, Tao Zhu, Shuhui Deng, Zhang Shuaishuai, MD, Mu Hao, PhD, Xiaoyan Feng, Yan Xu, MD, Wen Zhou, Lugui Qiu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4350.
https://doi.org/10.1182/blood.V130.Suppl_1.4350.4350
Published: 2017
Journal Articles

AURKA Regulates the Mechanism of ATR Mediated DNA Damage Response about Drug Resistance in Multiple Myeloma

Zhang Shuaishuai, MD, Yu Qin, An Gang, MD, Mu Hao, PhD, Yan Xu, MD, Shuhui Deng, Tengteng Yu, Wen Zhou, Lugui Qiu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5354.
https://doi.org/10.1182/blood.V130.Suppl_1.5354.5354
Published: 2017
Journal Articles

The Interaction of NEK2 with USP7 Causes Resistance to Proteasome Inhibitor in Multiple Myeloma

Reinaldo Franqui-Machin, Mu Hao, PhD, Bai Hua, Zhimin Gu, PhD, Xin Zhan, Hongwei Xu, Hasem Habelhah, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Lugui Qiu, MD, Ivana Frech, DSc, PhD MBA, Guido J. Tricot, MD PhD, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 593.
https://doi.org/10.1182/blood.V130.Suppl_1.593.593
Published: 2017
Journal Articles

Primary Plasma Cell Leukemia in China: A Retrospective Single Center Study

Tengteng Yu, Yan Xu, MD, An Gang, MD, Zengjun Li, Mu Hao, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5428.
https://doi.org/10.1182/blood.V130.Suppl_1.5428.5428
Published: 2017
Journal Articles

NEK2 Suppresses Cellular Senescence through Regulation of the β-Catenin/CCND2/RB Axis in Multiple Myeloma

Ye Yang, PhD, Guido J. Tricot, MD, PhD, Xia Jiliang, Zhimin Gu, PhD, Hongwei Xu, DDS, Mu Hao, PhD, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2024.
https://doi.org/10.1182/blood.V124.21.2024.2024
Published: 2014
Journal Articles

Hypermethylation of TAp73 Suppresses ABL1-Involved DNA Damage Response in Multiple Myeloma

Mu Hao, PhD, Yu Qin, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Gang An, MD PhD, Changhong Li, MD, Ye Yang, PhD, Zhimin Gu, PhD, Fenghuang Zhan, MD PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3374.
https://doi.org/10.1182/blood.V124.21.3374.3374
Published: 2014
Journal Articles

MiR-137 Contributes to Drug Susceptibility and Chromosomal Instability of Multiple Myeloma through Targeting AURKA

Yu Qin, PhD, Fei Li, MD, Xiaoqi Qin, Gang An, MD PhD, Mu Hao, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Wen Zhou, PhD, Hong Chang, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 5715.
https://doi.org/10.1182/blood.V124.21.5715.5715
Published: 2014
Journal Articles

Serum Mir-4254, Mir-19a and Mir-33b Are Potential Markers For Diagnosis and Prognostic Evaluation In Multiple Myeloma

Mu Hao, PhD., Meirong Zang, Qin Yu, Li Fei, Wenjuan Yang, Xiaoyan Feng, Fang Qi, Gang An, Changhong Li, Yan Xu, MD., Fenghuang Zhan, MD&PhD, Lugui Qiu, MD
Journal: Blood
Blood (2013) 122 (21): 3222.
https://doi.org/10.1182/blood.V122.21.3222.3222
Published: 2013
Journal Articles

Epigenetic Silencing Of Mir-137 Contributes To The Proliferation Of Multiple Myeloma By Targeting AURKA

Yu Qin, Fei Li, Gang An, Mu Hao, PhD., Meirong Zang, Lugui Qiu, MD
Journal: Blood
Blood (2013) 122 (21): 3144.
https://doi.org/10.1182/blood.V122.21.3144.3144
Published: 2013